m+Medelevator.RU
← Поиск публикаций
Clinical ophthalmology (Auckland, N.Z.) · 2020

Initial Outcomes with Customized Myopic LASIK, Guided by Automated Ray Tracing Optimization: A Novel Technique.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kanellopoulos Anastasios John

Аннотация

PURPOSE: Safety and efficacy of a novel automated ray tracing optimization in customization of excimer ablation in myopic LASIK.

METHODS: In a consecutive case series, 25 patients (50 eyes) undergoing femtosecond-laser-assisted myopic LASIK were evaluated. The novel, artificial-intelligence platform initially calculates the ablation profile based on a model eye for each case, based on interferometry axial length data. Low- and high-order aberration calculation is performed by raytracing based on wavefront and Scheimpflug tomography measurements, all from a single diagnostic device. Visual acuity, refractive error, keratometry, topography, high-order aberrations and contrast sensitivity were evaluated, over six months follow-up.

RESULTS: Change from pre- to 6 months post-operative: mean refractive error improved from -5.06 ± 2.54 diopters (D) (range -8.0 to -0.50 D) to -0.11 ± 0.09 D (range -0.25 to + 0.25); refractive astigmatism from -1.07 ± 0.91 D (range -4.25 to 0 D) to -0.15 ± 0.04 D (range -0.25 to 0); and topographic astigmatism from -1.65 ± 0.85 D to -0.26 ± 0.11 D (range -0.60 to 0). About 65% of eyes gained one line of vision and 38% 2 lines. Pre- to post-operative high-order aberration average: RMSh changed from 0.25 um to 0.35 um. Contrast sensitivity improved post-operatively.

CONCLUSION: We report safe and effective preliminary outcomes with a novel excimer laser customization by ray tracing optimization, for myopic LASIK treatments, employing several independent up-till-now diagnostics and a customized eye model reference for each case. It bears the potential advantage through total eye aberration data and ray tracing refraction calculation to offer improved and more predictable visual outcomes.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты